Camlin Fine Sciences Limited (BOM:532834)

Market Cap	56.82B
Revenue (ttm)	16.67B
Net Income (ttm)	-1.39B
Shares Out	187.92M
EPS (ttm)	-7.95
PE Ratio	77.22
Forward PE	40.86
Dividend	n/a
Ex-Dividend Date	n/a

Volume	123,723
Average Volume	196,515
Open	302.30
Previous Close	302.30
Day's Range	289.35 - 304.90
52-Week Range	95.80 - 304.55
Beta	0.50
RSI	78.99
Earnings Date	May 19, 2025

About Camlin Fine Sciences

Camlin Fine Sciences Limited, together with its subsidiaries, engages in the research, development, manufacture, and marketing of specialty chemicals, ingredients, and additive blend products in India and internationally. The company offers shelf-life solutions, which include antioxidants comprises Butylated Hydroxy Toluene and Ascorbyl palmitate; and emulsifiers, mold inhibitors, antibacterial agents, toxin binders, pellet binders, disinfectants, energizers, preservatives, thickening agents, and growth promoters, as well as plant-based antioxi...

• Industry: Chemicals and Allied Products
• Founded: 1931
• Employees: 624
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 532834

Financial Performance

In 2024, Camlin Fine Sciences's revenue was 16.67 billion, an increase of 3.31% compared to the previous year's 16.13 billion. Losses were -1.39 billion, 49.9% more than in 2023.